Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

2.

Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis.

Weiss SL, Yu M, Jennings L, Haymond S, Zhang G, Wainwright MS.

PLoS One. 2012;7(3):e33355. doi: 10.1371/journal.pone.0033355. Epub 2012 Mar 12.

3.

Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.

Aydemir O, Ozcan B, Yucel H, Bas AY, Demirel N.

J Matern Fetal Neonatal Med. 2015 May;28(8):977-82. doi: 10.3109/14767058.2014.939950. Epub 2014 Jul 22.

PMID:
24983667
4.

Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.

Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.

PLoS One. 2010 Mar 1;5(3):e9462. doi: 10.1371/journal.pone.0009462.

5.

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.

Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.

Atherosclerosis. 2014 Nov;237(1):38-44. doi: 10.1016/j.atherosclerosis.2014.07.033. Epub 2014 Aug 27.

PMID:
25194333
6.

Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.

Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.

Nephrol Dial Transplant. 2013 Apr;28(4):964-71. doi: 10.1093/ndt/gfs516. Epub 2012 Nov 4.

PMID:
23129820
7.

Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.

Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.

Minerva Anestesiol. 2010 May;76(5):325-33.

8.

Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.

Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G.

Endocrinology. 2008 Jun;149(6):3148-57. doi: 10.1210/en.2007-1558. Epub 2008 Feb 21.

PMID:
18292189
9.

Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.

Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.

Vasc Med. 2013 Aug;18(4):192-9. doi: 10.1177/1358863X13496488. Epub 2013 Jul 26.

PMID:
23892448
11.

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.

Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T.

Circ Res. 2003 Feb 7;92(2):226-33.

12.

Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.

Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.

Hypertens Res. 2005 Mar;28(3):255-62.

PMID:
16097370
13.

Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.

Visser M, Vermeulen MA, Richir MC, Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van Leeuwen PA, Oudemans-van Straaten HM.

Br J Nutr. 2012 May;107(10):1458-65. doi: 10.1017/S0007114511004648. Epub 2011 Dec 1.

PMID:
22129964
14.

Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamada S, Shoji H, Takeuchi M, Ueda S, Matsui T, Adachi H, Okuda S, Yamagishi S.

Pharmacol Res. 2009 Dec;60(6):515-8. doi: 10.1016/j.phrs.2009.05.002. Epub 2009 May 18.

PMID:
19450686
15.

Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.

Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.

Stroke. 2008 Jan;39(1):180-4. Epub 2007 Dec 6. Erratum in: Stroke. 2008 Aug;39(8): e142.

16.

Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.

Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.

Exp Gerontol. 2014 Feb;50:45-51. doi: 10.1016/j.exger.2013.11.004. Epub 2013 Nov 20.

PMID:
24269305
17.

Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.

Koch A, Weiskirchen R, Kunze J, Dückers H, Bruensing J, Buendgens L, Matthes M, Luedde T, Trautwein C, Tacke F.

J Crit Care. 2013 Dec;28(6):947-53. doi: 10.1016/j.jcrc.2013.05.016. Epub 2013 Aug 14.

PMID:
23953490
18.

Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation.

Staab EB, Weigel J, Xiao F, Madayiputhiya N, Wyatt TA, Wells SM.

J Immunotoxicol. 2015 Jul-Sep;12(3):273-82. doi: 10.3109/1547691X.2014.961619. Epub 2014 Nov 19.

PMID:
25913572
19.

Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.

Feng M, Liu L, Guo Z, Xiong Y.

Eur J Pharmacol. 2008 Apr 14;584(1):49-56. doi: 10.1016/j.ejphar.2008.01.029. Epub 2008 Feb 5.

PMID:
18342305
20.

Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.

Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T.

Amino Acids. 2012 Aug;43(2):805-11. doi: 10.1007/s00726-011-1136-3. Epub 2011 Nov 11.

PMID:
22075968

Supplemental Content

Support Center